Global Branded Generics Market Research Report 2021
Table of Contents1 Branded Generics Market Overview
1.1 Product Overview and Scope of Branded Generics
1.2 Branded Generics Segment by Type
1.2.1 Global Branded Generics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Topical
1.2.5 Other
1.3 Branded Generics Segment by Application
1.3.1 Branded Generics Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Diabetes
1.3.5 Neurology
1.3.6 Gastrointestinal Diseases
1.3.7 Others
1.4 Global Branded Generics Market Size Estimates and Forecasts
1.4.1 Global Branded Generics Revenue 2016-2027
1.4.2 Global Branded Generics Sales 2016-2027
1.4.3 Branded Generics Market Size by Region: 2016 Versus 2021 Versus 2027
2 Branded Generics Market Competition by Manufacturers
2.1 Global Branded Generics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Branded Generics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Branded Generics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Branded Generics Manufacturing Sites, Area Served, Product Type
2.5 Branded Generics Market Competitive Situation and Trends
2.5.1 Branded Generics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Branded Generics Players Market Share by Revenue
2.5.3 Global Branded Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Branded Generics Retrospective Market Scenario by Region
3.1 Global Branded Generics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Branded Generics Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Branded Generics Market Facts & Figures by Country
3.3.1 North America Branded Generics Sales by Country
3.3.2 North America Branded Generics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Branded Generics Market Facts & Figures by Country
3.4.1 Europe Branded Generics Sales by Country
3.4.2 Europe Branded Generics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Branded Generics Market Facts & Figures by Region
3.5.1 Asia Pacific Branded Generics Sales by Region
3.5.2 Asia Pacific Branded Generics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Branded Generics Market Facts & Figures by Country
3.6.1 Latin America Branded Generics Sales by Country
3.6.2 Latin America Branded Generics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Branded Generics Market Facts & Figures by Country
3.7.1 Middle East and Africa Branded Generics Sales by Country
3.7.2 Middle East and Africa Branded Generics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Branded Generics Historic Market Analysis by Type
4.1 Global Branded Generics Sales Market Share by Type (2016-2021)
4.2 Global Branded Generics Revenue Market Share by Type (2016-2021)
4.3 Global Branded Generics Price by Type (2016-2021)
5 Global Branded Generics Historic Market Analysis by Application
5.1 Global Branded Generics Sales Market Share by Application (2016-2021)
5.2 Global Branded Generics Revenue Market Share by Application (2016-2021)
5.3 Global Branded Generics Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Mylan NV
6.1.1 Mylan NV Corporation Information
6.1.2 Mylan NV Description and Business Overview
6.1.3 Mylan NV Branded Generics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Mylan NV Product Portfolio
6.1.5 Mylan NV Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Branded Generics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis AG Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 Eva Pharmaceutical Industries
6.3.1 Eva Pharmaceutical Industries Corporation Information
6.3.2 Eva Pharmaceutical Industries Description and Business Overview
6.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Eva Pharmaceutical Industries Product Portfolio
6.3.5 Eva Pharmaceutical Industries Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Branded Generics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sun Pharmaceutical Industries Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Aspen Pharmacare Holding
6.6.1 Aspen Pharmacare Holding Corporation Information
6.6.2 Aspen Pharmacare Holding Description and Business Overview
6.6.3 Aspen Pharmacare Holding Branded Generics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Aspen Pharmacare Holding Product Portfolio
6.6.5 Aspen Pharmacare Holding Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Branded Generics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Abbott Laboratories Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Bausch Health
6.8.1 Bausch Health Corporation Information
6.8.2 Bausch Health Description and Business Overview
6.8.3 Bausch Health Branded Generics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bausch Health Product Portfolio
6.8.5 Bausch Health Recent Developments/Updates
7 Branded Generics Manufacturing Cost Analysis
7.1 Branded Generics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Branded Generics
7.4 Branded Generics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Branded Generics Distributors List
8.3 Branded Generics Customers
9 Branded Generics Market Dynamics
9.1 Branded Generics Industry Trends
9.2 Branded Generics Growth Drivers
9.3 Branded Generics Market Challenges
9.4 Branded Generics Market Restraints
10 Global Market Forecast
10.1 Branded Generics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Branded Generics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Branded Generics by Type (2022-2027)
10.2 Branded Generics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Branded Generics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Branded Generics by Application (2022-2027)
10.3 Branded Generics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Branded Generics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Branded Generics by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Branded Generics Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Branded Generics Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Branded Generics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Branded Generics Covered in This Study
Table 5. Global Branded Generics Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Branded Generics Sales Share by Manufacturers (2016-2021)
Table 7. Global Branded Generics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Branded Generics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Branded Generics Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Branded Generics Manufacturing Sites and Area Served
Table 11. Manufacturers Branded Generics Product Type
Table 12. Global Branded Generics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Branded Generics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Branded Generics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Branded Generics Sales by Region (2016-2021) & (K MT)
Table 16. Global Branded Generics Sales Market Share by Region (2016-2021)
Table 17. Global Branded Generics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Branded Generics Sales by Country (2016-2021) & (K MT)
Table 19. North America Branded Generics Sales Market Share by Country (2016-2021)
Table 20. North America Branded Generics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Branded Generics Revenue Market Share by Country (2016-2021)
Table 22. Europe Branded Generics Sales by Country (2016-2021) & (K MT)
Table 23. Europe Branded Generics Sales Market Share by Country (2016-2021)
Table 24. Europe Branded Generics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Branded Generics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Branded Generics Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Branded Generics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Branded Generics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Branded Generics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Branded Generics Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Branded Generics Sales Market Share by Country (2016-2021)
Table 32. Latin America Branded Generics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Branded Generics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Branded Generics Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Branded Generics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Branded Generics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Branded Generics Revenue Market Share by Country (2016-2021)
Table 38. Global Branded Generics Sales (K MT) by Type (2016-2021)
Table 39. Global Branded Generics Sales Market Share by Type (2016-2021)
Table 40. Global Branded Generics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Branded Generics Revenue Share by Type (2016-2021)
Table 42. Global Branded Generics Price (USD/MT) by Type (2016-2021)
Table 43. Global Branded Generics Sales (K MT) by Application (2016-2021)
Table 44. Global Branded Generics Sales Market Share by Application (2016-2021)
Table 45. Global Branded Generics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Branded Generics Revenue Share by Application (2016-2021)
Table 47. Global Branded Generics Price (USD/MT) by Application (2016-2021)
Table 48. Mylan NV Corporation Information
Table 49. Mylan NV Description and Business Overview
Table 50. Mylan NV Branded Generics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Mylan NV Branded Generics Product
Table 52. Mylan NV Recent Developments/Updates
Table 53. Novartis AG Corporation Information
Table 54. Novartis AG Description and Business Overview
Table 55. Novartis AG Branded Generics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Novartis AG Branded Generics Product
Table 57. Novartis AG Recent Developments/Updates
Table 58. Eva Pharmaceutical Industries Corporation Information
Table 59. Eva Pharmaceutical Industries Description and Business Overview
Table 60. Eva Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Eva Pharmaceutical Industries Branded Generics Product
Table 62. Eva Pharmaceutical Industries Recent Developments/Updates
Table 63. Pfizer Corporation Information
Table 64. Pfizer Description and Business Overview
Table 65. Pfizer Branded Generics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Pfizer Branded Generics Product
Table 67. Pfizer Recent Developments/Updates
Table 68. Sun Pharmaceutical Industries Corporation Information
Table 69. Sun Pharmaceutical Industries Description and Business Overview
Table 70. Sun Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Sun Pharmaceutical Industries Branded Generics Product
Table 72. Sun Pharmaceutical Industries Recent Developments/Updates
Table 73. Aspen Pharmacare Holding Corporation Information
Table 74. Aspen Pharmacare Holding Description and Business Overview
Table 75. Aspen Pharmacare Holding Branded Generics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Aspen Pharmacare Holding Branded Generics Product
Table 77. Aspen Pharmacare Holding Recent Developments/Updates
Table 78. Abbott Laboratories Corporation Information
Table 79. Abbott Laboratories Description and Business Overview
Table 80. Abbott Laboratories Branded Generics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Abbott Laboratories Branded Generics Product
Table 82. Abbott Laboratories Recent Developments/Updates
Table 83. Bausch Health Corporation Information
Table 84. Bausch Health Description and Business Overview
Table 85. Bausch Health Branded Generics Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Bausch Health Branded Generics Product
Table 87. Bausch Health Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Branded Generics Distributors List
Table 91. Branded Generics Customers List
Table 92. Branded Generics Market Trends
Table 93. Branded Generics Growth Drivers
Table 94. Branded Generics Market Restraints
Table 95. Global Branded Generics Sales Forecast by Type (2022-2027) & (K MT)
Table 96. Global Branded Generics Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Branded Generics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Branded Generics Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Branded Generics Sales Forecast by Application (2022-2027) & (K MT)
Table 100. Global Branded Generics Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Branded Generics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Branded Generics Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Branded Generics Sales Forecast by Region (2022-2027) & (K MT)
Table 104. Global Branded Generics Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Branded Generics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Branded Generics Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Branded Generics
Figure 2. Global Branded Generics Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Parenteral Product Picture
Figure 5. Topical Product Picture
Figure 6. Other Product Picture
Figure 7. Global Branded Generics Market Share by Application in 2020 & 2027
Figure 8. Oncology
Figure 9. Cardiovascular Diseases
Figure 10. Diabetes
Figure 11. Neurology
Figure 12. Gastrointestinal Diseases
Figure 13. Others
Figure 14. Global Branded Generics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Branded Generics Market Size 2016-2027 (US$ Million)
Figure 16. Global Branded Generics Sales 2016-2027 (K MT)
Figure 17. Global Branded Generics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Branded Generics Sales Share by Manufacturers in 2020
Figure 19. Global Branded Generics Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Branded Generics Players: Market Share by Revenue in 2020
Figure 21. Branded Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Branded Generics Sales Market Share by Region (2016-2021)
Figure 23. Global Branded Generics Sales Market Share by Region in 2020
Figure 24. Global Branded Generics Revenue Market Share by Region (2016-2021)
Figure 25. Global Branded Generics Revenue Market Share by Region in 2020
Figure 26. U.S. Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Branded Generics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Branded Generics by Type (2016-2021)
Figure 51. Sales Market Share of Branded Generics by Application (2016-2021)
Figure 52. Sales Market Share of Branded Generics by Application in 2020
Figure 53. Revenue Share of Branded Generics by Application (2016-2021)
Figure 54. Revenue Share of Branded Generics by Application in 2020
Figure 55. Manufacturing Cost Structure of Branded Generics
Figure 56. Manufacturing Process Analysis of Branded Generics
Figure 57. Branded Generics Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed